HeimKRK • WSE
add
Krka d.d. Novo Mesto
Við síðustu lokun
608,00 zł
Dagbil
606,00 zł - 612,00 zł
Árabil
450,00 zł - 622,00 zł
Meðalmagn
90,00
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (EUR) | mar. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 486,14 m. | 6,10% |
Rekstrarkostnaður | 165,75 m. | 3,92% |
Nettótekjur | 98,88 m. | 11,08% |
Hagnaðarhlutfall | 20,34 | 4,68% |
Hagnaður á hvern hlut | — | — |
EBITDA | 137,52 m. | -5,32% |
Virkt skatthlutfall | 16,75% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (EUR) | mar. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 563,62 m. | -0,53% |
Heildareignir | 2,86 ma. | 3,42% |
Heildarskuldir | 582,22 m. | 5,25% |
Eigið fé alls | 2,28 ma. | — |
Útistandandi hlutabréf | 30,82 m. | — |
Eiginfjárgengi | 8,31 | — |
Arðsemi eigna | 10,16% | — |
Ávöxtun eigin fjár | 12,74% | — |
Peningaflæði
Breyting á handbæru fé
| (EUR) | mar. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 98,88 m. | 11,08% |
Handbært fé frá rekstri | 62,26 m. | 134,32% |
Reiðufé frá fjárfestingum | 19,16 m. | 183,47% |
Reiðufé frá fjármögnun | -8,83 m. | -23,98% |
Breyting á handbæru fé | 72,59 m. | 2.503,58% |
Frjálst peningaflæði | 4,20 m. | 130,94% |
Um
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. As well as a number of companies and representative offices abroad, Krka also had production and distribution centers in Russia, Poland, Croatia, and Germany. Krka sells products to more than 70 countries.
In 2018, Krka Group's total sales amounted to 1.332 billion euros. Over the previous five years, average annual sales growth had been at 2.9% rate. At the end of 2018, Krka Group had 11,390 employees. Wikipedia
Framkvæmdastjóri
Stofnsett
23. apr. 1954
Vefsvæði
Starfsfólk
12.675
